drugset / Trial / NCT04254549
Rifaximin in Patients With Diabetic Gastroparesis
RandomizedParallel-groupDouble-blindTreatment
Summary
Researchers are trying to determine if subjects with diabetic gastroparesis and symptoms of bloating will have a greater improvement in bloating symptoms when treated with rifaximin.
Timeline
- Start
- 2019-06-14
- Primary completion
- 2025-04-08
- Completion
- 2025-04-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rifaximin | Other / unclassified | 550 mg | Oral |